|
Valoración de DCF de Himadri Specialty Chemical Limited (HSCL.NS)
IN | Basic Materials | Chemicals - Specialty | NSE
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Himadri Speciality Chemical Limited (HSCL.NS) Bundle
¡Explore el potencial financiero de Himadri Specialty Chemical Limited (HSCLNS) utilizando nuestra calculadora DCF fácil de usar! Simplemente ingrese sus proyecciones para el crecimiento, los márgenes y los gastos para calcular el valor intrínseco de los HSCLN y refinar su enfoque de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17,936.7 | 16,793.1 | 27,907.3 | 41,718.4 | 41,846.1 | 53,312.2 | 67,920.0 | 86,530.5 | 110,240.4 | 140,447.0 |
| Revenue Growth, % | 0 | -6.38 | 66.18 | 49.49 | 0.30605 | 27.4 | 27.4 | 27.4 | 27.4 | 27.4 |
| EBITDA | 2,850.5 | 1,444.9 | 1,363.9 | 3,836.7 | 6,844.6 | 5,857.5 | 7,462.5 | 9,507.3 | 12,112.4 | 15,431.3 |
| EBITDA, % | 15.89 | 8.6 | 4.89 | 9.2 | 16.36 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 |
| Depreciation | 392.4 | 469.7 | 495.5 | 508.5 | 498.6 | 977.8 | 1,245.8 | 1,587.1 | 2,022.0 | 2,576.0 |
| Depreciation, % | 2.19 | 2.8 | 1.78 | 1.22 | 1.19 | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 |
| EBIT | 2,458.0 | 975.1 | 868.4 | 3,328.2 | 6,346.0 | 4,879.7 | 6,216.8 | 7,920.2 | 10,090.4 | 12,855.2 |
| EBIT, % | 13.7 | 5.81 | 3.11 | 7.98 | 15.17 | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 |
| Total Cash | 419.9 | 1,281.7 | 2,634.6 | 6,495.6 | 2,207.4 | 4,292.6 | 5,468.8 | 6,967.3 | 8,876.3 | 11,308.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3,087.5 | 4,764.8 | 5,198.6 | 5,259.7 | 6,556.5 | 9,861.8 | 12,563.9 | 16,006.5 | 20,392.4 | 25,980.1 |
| Account Receivables, % | 17.21 | 28.37 | 18.63 | 12.61 | 15.67 | 18.5 | 18.5 | 18.5 | 18.5 | 18.5 |
| Inventories | 4,051.9 | 3,394.0 | 7,715.1 | 5,442.2 | 7,025.2 | 10,692.2 | 13,622.0 | 17,354.5 | 22,109.7 | 28,167.9 |
| Inventories, % | 22.59 | 20.21 | 27.65 | 13.05 | 16.79 | 20.06 | 20.06 | 20.06 | 20.06 | 20.06 |
| Accounts Payable | 2,294.0 | 1,529.1 | 7,786.0 | 3,455.9 | 5,703.6 | 7,645.9 | 9,740.9 | 12,409.9 | 15,810.3 | 20,142.5 |
| Accounts Payable, % | 12.79 | 9.11 | 27.9 | 8.28 | 13.63 | 14.34 | 14.34 | 14.34 | 14.34 | 14.34 |
| Capital Expenditure | -2,468.6 | -351.4 | -231.6 | -831.5 | -527.5 | -2,126.0 | -2,708.5 | -3,450.6 | -4,396.1 | -5,600.7 |
| Capital Expenditure, % | -13.76 | -2.09 | -0.82989 | -1.99 | -1.26 | -3.99 | -3.99 | -3.99 | -3.99 | -3.99 |
| Tax Rate, % | 28.42 | 28.42 | 28.42 | 28.42 | 28.42 | 28.42 | 28.42 | 28.42 | 28.42 | 28.42 |
| EBITAT | 2,601.5 | 717.1 | 665.1 | 2,564.9 | 4,542.5 | 3,891.8 | 4,958.1 | 6,316.7 | 8,047.5 | 10,252.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -4,320.0 | -949.0 | 2,431.1 | 123.5 | 3,881.5 | -2,286.4 | -41.5 | -52.9 | -67.3 | -85.8 |
| WACC, % | 8.05 | 7.97 | 7.98 | 7.98 | 7.96 | 7.99 | 7.99 | 7.99 | 7.99 | 7.99 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2,302.8 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | -89 | |||||||||
| Terminal Value | -2,238 | |||||||||
| Present Terminal Value | -1,524 | |||||||||
| Enterprise Value | -3,827 | |||||||||
| Net Debt | 3,901 | |||||||||
| Equity Value | -7,728 | |||||||||
| Diluted Shares Outstanding, MM | 448 | |||||||||
| Equity Value Per Share | -17.23 |
What You Will Receive
- Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring up-to-date financials for Himadri Speciality Chemical Limited (HSCLNS).
- Real-World Data: Access to historical performance data and forward-looking estimates (highlighted in the yellow cells).
- Flexible Forecasting: Adjust assumptions for revenue growth, EBITDA %, and WACC as needed.
- Instant Calculations: Quickly observe how your inputs affect the valuation of Himadri Speciality Chemical Limited (HSCLNS).
- Professional-Grade Tool: Designed specifically for investors, CFOs, consultants, and financial analysts.
- User-Friendly Layout: Organized for clarity and ease of navigation, complete with step-by-step guidance.
Key Features
- Comprehensive DCF Calculator: Offers in-depth unlevered and levered DCF valuation models tailored for Himadri Speciality Chemical Limited (HSCLNS).
- WACC Calculator: Features a pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Adjust growth projections, capital investments, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Himadri Speciality Chemical Limited (HSCLNS).
- Interactive Dashboard and Charts: Visual representations that summarize essential valuation metrics for straightforward analysis.
How It Works
- Download: Get the pre-prepared Excel file containing Himadri Speciality Chemical Limited’s (HSCLNS) financial data.
- Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to suit your analysis.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time for accurate assessments.
- Test Scenarios: Generate various projections and instantly compare their results.
- Make Decisions: Leverage the valuation outcomes to inform your investment choices.
Why Opt for Himadri Speciality Chemical Limited (HSCLNS) Calculator?
- Time Efficiency: Skip the hassle of building a DCF model from the ground up – it's pre-configured for your convenience.
- Enhanced Precision: Dependable financial data and accurate formulas minimize valuation errors.
- Completely Customizable: Adjust the model to mirror your unique assumptions and forecasts.
- User-Friendly: Intuitive charts and outputs simplify results analysis.
- Preferred by Professionals: Crafted for experts who prioritize accuracy and ease of use.
Who Should Use Himadri Speciality Chemical Limited (HSCLNS)?
- Investors: Accurately assess HSCLNS’s fair value prior to making investment choices.
- Financial Executives: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
- Consultants: Efficiently customize the template for client valuation reports.
- Entrepreneurs: Acquire insights into the financial modeling practices of leading chemical companies.
- Educators: Employ it as a teaching resource to illustrate valuation techniques.
Contents of the Template
- Detailed DCF Model: An editable template featuring in-depth valuation calculations for HSCLNS.
- Market Data: Historical and projected financial information for Himadri Speciality Chemical Limited (HSCLNS) preloaded for comprehensive analysis.
- Adjustable Variables: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly reports for enhanced understanding.
- Essential Ratios: Integrated analysis covering profitability, efficiency, and leverage metrics.
- Visual Dashboard: Charts and tables designed to present clear, actionable insights.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.